Pieris Pharmaceuticals
PIRS
#9964
Rank
A$29.69 M
Marketcap
$22.49
Share price
-15.58%
Change (1 day)
7.69%
Change (1 year)

Earnings for Pieris Pharmaceuticals (PIRS)

Earnings in 2024 (TTM): -A$33.78 Million

According to Pieris Pharmaceuticals's latest financial reports the company's current earnings are A$19.57 Million. In 2022 the company made an earning of -A$55.05 Million, an increase over its 2021 earnings that were of -A$75.66 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Pieris Pharmaceuticals from 2015 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$33.78 Million
2022 -A$55.05 Million-27.24%
2021 -A$75.66 Million23.4%
2020 -A$61.31 Million45.53%
2019 -A$42.13 Million-5.89%
2018 -A$44.77 Million63.59%
2017 -A$27.37 Million-26.92%
2016 -A$37.45 Million63.39%
2015 -A$22.92 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$0.14 Billion 258.88%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$9.07 Million-75.21%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.14 B-3,219.21%๐Ÿ‡บ๐Ÿ‡ธ USA